The development of a vaccine - a highly regulated process
© 2021 Published by Elsevier Masson SAS..
The development of a vaccine requires a very high level of expertise. It is a long and complex process. But in the fight against Covid-19, exceptional research and regulatory efforts have been made to successfully deliver a vaccine solution in less than a year.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Actualites pharmaceutiques - 60(2021), 606 vom: 10. Mai, Seite 45-48 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
La fabrication d’un vaccin, un processus très encadré |
|---|
| Beteiligte Personen: |
Blin, Aurore [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Control |
|---|
| Anmerkungen: |
Date Revised 12.05.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.actpha.2021.03.019 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM325244138 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM325244138 | ||
| 003 | DE-627 | ||
| 005 | 20231225192031.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.actpha.2021.03.019 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1084.xml |
| 035 | |a (DE-627)NLM325244138 | ||
| 035 | |a (NLM)33972812 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Blin, Aurore |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The development of a vaccine - a highly regulated process |
| 246 | 3 | 3 | |a La fabrication d’un vaccin, un processus très encadré |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 12.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2021 Published by Elsevier Masson SAS. | ||
| 520 | |a The development of a vaccine requires a very high level of expertise. It is a long and complex process. But in the fight against Covid-19, exceptional research and regulatory efforts have been made to successfully deliver a vaccine solution in less than a year | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a control | |
| 650 | 4 | |a manufacturing | |
| 650 | 4 | |a production | |
| 650 | 4 | |a vaccine | |
| 773 | 0 | 8 | |i Enthalten in |t Actualites pharmaceutiques |d 1961 |g 60(2021), 606 vom: 10. Mai, Seite 45-48 |w (DE-627)NLM136159966 |x 0515-3700 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2021 |g number:606 |g day:10 |g month:05 |g pages:45-48 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.actpha.2021.03.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2021 |e 606 |b 10 |c 05 |h 45-48 | ||